Dr David Martin is Chairman of EMCAM Risk management, Underwriters of the world’s intangible assets in 168 countries, track and  trace Patent applications, Federal grants and government e records around the world, to monitor financial and corporate responsibility. Dr Martin has shared US  Patent records with the scientific community, recording the twenty year history leading up to Covid-19. This is a long video, if even part of it is true there are profound implications. Key points are below.  See video  

September 2000 – EMCAM was part of the investigation into the origins of the anthrax outbreak in the US and the unusual behaviour around ciprofloxacin, the drug manufactured by Bayers one of the largest pharmaceutical companies in the world, used as a potential treatment for anthrax. In the Fall 0f 2001 EMCAM began monitoring an enormous number of bacterial pathogens being patented through government agencies NIH, NIAID, AMRAD (US Armed Services Infectious Disease Programme) and other international agencies who collaborated with them. There were concerns that corona virus was being seen not only as a potential manipulable agent for use as a vaccine vector but was also clearly being considered as a biological weapon candidate.

The US Patent Office is responsible for safe-guarding intellectual property to inventors and businesses, providing a verifiable public record. Documentation in the records of Spring 2020, show 120 pieces of evidence proving a programme of research and development into Corona Virus existing over more than 20 years. Records show that the reported gene sequence stated as ‘novel’ is not in fact new at all, for the Corona virus is not new to the human condition and has for a long time been part of the sequence of proteins that circulate, associated with the common cold. Records also show that SARS, the viral respiratory disease caused by the corona virus is not a natural progression of a zoonotic modification of a corona virus,  in other words it was made in the laboratory.

In 1984, Anthony Fauci was appointed Director of NIAID (National Institute of Allergy and Infectious Diseases) The malleability of Corona virus was found to be a potential candidate for HIV vaccines.

  • 1999, Fauci funded the University of North Carolina Chapel Hill laboratory research programme, creating a NIAID built infectious replication of defective corona virus, specifically targeted for human lung epithelia.
  • January 28th, 2000 – US Patent 6372224 was the first vaccine application for Corona virus, made by Pfizer specifically for the S Spike protein. This was a Spike protein vaccine for a canine. (Ralph Berrick Professor of Microbiology and Immunology at the The University of North Carolina at Chapel Hill worked on 2 target candidates, rabbits and canines.)
  • April 19th 2002 – US Patent Application 7279327 clearly lays out very specific gene sequencing, demonstrating that we knew that the ACE 2 Receptor, the ACE 2 binding Domain, the S1 Spike Protein and other elements of what we have come to know as Covid -19 was not only engineered in the laboratory but could be ‘synthetically modified using gene sequencing technologies, taking computer code and turning it into a pathogen or an intermediary of a pathogen.’  Gene technology to harness corona virus as a VECTOR to distribute HIV vaccine was funded exclusively in the early days.
  • April 2003 – Patent Application 7220852 filed by US Centre for Disease Control and Prevention (CDC)  The entire gene sequence of what became known as Sars Corona virus was filed under this application, justified by their PR team as “so that everyone would be free to research corona virus.”  This was disingenuous and a violation of US Code 35 Section 101 which states that ‘You cannot patent a naturally occurring substance’. The Patent Office rejected the application twice as un-patentable because the gene sequence was already in the public domain having already found 99.9% identity with the  existing corona virus recorded.
  • Patent 46592703P and Patent 776521  included and covered a series of derivative patents of multiple subject matter covering not only the gene sequence of Sars Corona virus but also of the means of detecting it using RTPCR, (reverse transcription-polymerase chain reaction, the most sensitive technique for mRNA detection and quantitation currently available.)
  • Moderna received the spike protein sequence by phone from the vaccine research centre NIAID prior to the definition of the subclade . (a subclade is a  genetic subgrouping)
  • APRIL 2003Patent 7151163 was filed three days later by Sequoia Pharmaceuticals on anti viral agents, treatment and control of infections by corona virus.

THE QUESTION ARISES – HOW COULD THERE BE A TREATMENT FOR SOMETHING ONLY INVENTED 3 DAYS EARLIER?  Answer: The Sequoia Pharmaceuticals patent was issued and published before the initial CDC Patent number 7220852 on corona virus was approved. Patent Office records  available in the public archive office, show that after the initial  CDC Patent was rejected twice, an Appeal fine was paid the Patent Office to keep this information private, patent approval was not given until 2006/7.

‘If you own the patent of the gene itself and you own the patent on its detection you have a cunning advantage of being able to control 100% of the provenance of not only the virus itself but also of its detection: You have entire scientific and message control.’ 


The RICO Act is a United States federal law defining criminal conspiracy, racketeering  and collusion. Rico provides for extended criminal penalties and a civil cause of action for acts performed as part of an ongoing criminal organization, causing some to query the  possibility of a future RICO action. ‘This is the very definition of criminal conspiracy, racketeering and collusion – it is evidence. The degree to which that information could have been known to anyone  except for  insider information is zero, not physically possible. You cannot have information in the future informing something which does not yet exist.’

5TH June 2008  –  DARPA  the US Defense Advanced Research Projects Agency responsible for the development of emerging technologies for use by the military, actively took an interest in corona virus as a biological weapon.

  •  5th June 2008- Ablynx (now a part of Sanofi a French multinational pharmaceutical company) filed a specific number of patents in sequence for the novel feature of the SARS COV 2 virus. They specifically targeted what was called the Polybasic cleavage site, for SARS COV, the novel spike protein and the ACE 2 receptor binding domain allegedly novel to SARS COV 2 .
  •  May 2014 – The part of the NIAID headed by Fauci, awarded a $3.4 million grant to the New York-based EcoHealth Alliance working in partnership with Wuhan bio security lab China. This was later withdrawn.
  • November  24  2015  – Patent application 9193780 was made after the ‘gain of function moratorium’ of 2014 when funding was paused due to concerns by leading scientists regarding unacceptable risks of creating a pandemic.

Moderna then began negotiating with Arbutis Pharmaceuticals and Acuitas, two Canadian companies who owned the patent on the lipid nanoparticle required to deliver the injection of the mrna fragment.

  • November 2015 Moderna entered into a cooperative research and development agreement with Chapel Hill North Carolina University with respect of using the lipid nanoparticle to facilitate delivery of the spike protein. A potential candidate vaccine before a pathogen release had supposedly occurred.
  • 2016  Ralph Berrick published his paper stating that SARS Corona Virus was poised for human emergence, stating in a speech  ‘You can make a lot of money with this’.
  • 2016/17/19 – A  series of patents all covering not only the rna strands but sub components of gene strands, were all issued to Ablynx and Sanofi.

The Bidol Rights Act states that if the US government has paid for research it is entitled to benefit from the research as their right or at their whim. So why in 2017/2018 does NIAID  have to take ownership of the patent that they already have rights to and file a certificate of ownership? Perhaps due to the complexity of 73 Patent applications which existed by 2016 from multi national pharmaceutical companies, morphing and vying for commercial exploitation.

Sequoia Pharmaceuticals  is engaged in the discovery and development of antiviral therapeutics, focusing on combating drug-resistant viruses and Ablynx Pharmaceuticals is engaged in the discovery and development of nano-bodies. Ablynx is a subsidiary of Sanofi the fifth largest  pharmaceutical company in the world.



  • 2018 – Patent 7279327 on the recombitant nature of lung targeted corona virus was transferred from the University of N Carolina to NIH, the US National Institute of Health.
  • March 2019 – Moderna  suddenly revitalised and amended 4 failed Patent filings to specifically make reference to ‘a deliberate or accidental release of corona virus’  to begin the process of vaccine development.
  • November 2019 – University of Carolina and Moderna began the sequencing of a spike protein on the single patent required to develop the Vaccine Research mandate.
  • August 2020 – Funding of  $7.5 million was reinstated for Echo Health Alliance with  stringent precautions. Peter Dazsak, the Chairman stated “we have an ongoing collaboration, we have data that we’ve gathered over 15 years of working in China — 5 years under a previous grant from the NIH — which haven’t been published yet”

Peter Dazsak was also part of the World Health Organisation team investigating the source of the Covid-19 outbreak. He is  quoted in 2015  We need to increase public understanding of the need for medical counter measures such as a pan corona virus vaccine..a key driver is the media and the economics will follow the hype. We need to use that hype to our advantage to get to the real issues- investors who will respond if they see profit at the end of the process”

The old adage comes to mind



Listen to: ‘Wake up Ye Sleepers’ – Clann Destiny Macwestie


See also:

Censorship- Silencing the Covid Whistle Blowers

Covid Vaccine – A ‘Clever Trick’?